Craniopharyngioma and Pregnancies
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jan 24, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how pregnancy affects women who have had a rare type of brain tumor called craniopharyngioma. These tumors can cause complicated health issues, and there is not much information available about how pregnancy impacts women with this condition. The researchers at Pitié Salpêtrière hospital are following women who have had craniopharyngioma to learn more about their experiences during pregnancy and to see how it might affect their tumors.
To participate in this study, women need to be at least 18 years old and should have a history of craniopharyngioma. They also need to be comfortable with joining a research project. Participants will have the opportunity to share their pregnancy experiences, and the study aims to provide valuable insights that could help other patients in the future. This trial is currently seeking participants, so if you or someone you know fits the criteria, it could be a chance to contribute to important research.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients aged at least 18 years old
- • Patients with or having had a craniopharyngioma
- • Patients informed and not opposed to participation in research
- Exclusion Criteria:
- • Patients who don't speak french
- • Patients without medical care insurance
- • Patients under legal protection
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Anne BACHELOT, MD, PhD
Study Chair
Assistance Publique - Hôpitaux de Paris
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported